C.E. Credits

The speakers below have been approved for CME, CE, or CEU credits. To redeem your credits, locate the presentation you watched and click on the CME/CE/CEU buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here


JUN 20 - 21 2018

Precision Medicine 2018

Our 3rd Annual Precision Medicine Virtual Conference is now available On Demand!

Precision Medicine 2018 will continue the dialogue and provide updates on new efforts in drug discoveries, developments in FDA regulatory structures, and the integration of genetics on disease progression. 

Precision Medicine is becoming an integral part of research in the science community. The discipline not only involves individual genetic information, but also environmental, behavioral, and clinical data. A combination of these factors allows researchers to put together a comprehensive view of each patient that aids in their search for precision approaches to health maintenance, disease prevention, and therapies.

Attendees of the on-demand 2018 virtual event will learn from industry experts on a range of topics, such as NGS applications and technology development, large-scale genomics data sets, large-scale sequencing efforts, pharmagenomics and drug development to name a few. Presentations on developments for diagnostic and treatment for diseases such as cancer and Crohn's will also be available. 

Topic's for this years event included: 

  • New Developments in Cancer Diagnostics and Therapeutics 
  • Pharmacogenomics 
  • What’s Next in Precision Medicine
  • Disease-Specific Research

 

Don't forget to participate in our Leaderboard and Scavenger Hunt to win one of our Free Science T-shirts!  

Continuing Education
By participating in this virtual event and watching webcast presentations, you can earn Free Continuing Education (CE) and/or Continuing Medical Education (CME) credits. To earn educational credits, you must view an entire presentation. Following the presentation. you must click on the educational credit link provided for that particular speaker and follow the required process. Once you have completed the process, you will receive a certificate for the educational credit.

Use #LRprecisionmed to follow the conversation!

 


Speakers

Show Resources
You May Also Like
SEP 14, 2016 06:30 AM PDT
C.E. CREDITS
SEP 14, 2016 06:30 AM PDT
An industry leader in delivering instrument systems, reagents, and services to life science researchers,Beckman Coulter Life Sciences helps enable new discoveries in biology-based research...
NOV 02, 2016 06:00 AM PDT
C.E. CREDITS
NOV 02, 2016 06:00 AM PDT
The 7th annual Clinical Diagnostics & Research conference is now On Demand!  This premiere venue discusses the latest advances in clinical diagnostics, research and medicine. The con...
NOV 08, 2017 06:00 AM PST
C.E. CREDITS
NOV 08, 2017 06:00 AM PST
LabRoots invites you to the 8th annual Clinical Diagnostics & Research free online conference! Clinical diagnostics is an ever-changing field of medicine and research, challenged wit...
NOV 11, 2015 06:00 AM PST
C.E. CREDITS
NOV 11, 2015 06:00 AM PST
Welcome to LabRoots’ 6th Annual Clinical Diagnostics & Research free online conference! The event is now available on-demand and you can attend sessions including keynotes...
MAY 28, 2014 06:00 AM PDT
C.E. CREDITS
MAY 28, 2014 06:00 AM PDT
This year will be our 5th annual Clinical Diagnostics & Research online conference. Attendees can earn free CME and CE Credits. The theme of this conference is a range of medical and clin...
FEB 22, 2017 06:00 AM PST
C.E. CREDITS
FEB 22, 2017 06:00 AM PST
Precision Medicine 2017 was a success and is now availabe On Demand!Imagine receiving a full diagnosis from a simple blood test, or the ability to tailor the perfect treatment to your ind...
Posters

POSTER SUBMISSION GUIDELINES

Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Posters should be submitted as a PowerPoint file. Presentations should incorporate illustrative materials such as tables, graphs, photographs, and large-print text. This content is not peer-reviewed. Submission is free.

SUBMIT YOUR ABSTRACT

Enter the following information to this Submission Form:

  • Poster Title
  • Your Name
  • Your Institution
  • Your Email
  • Abstract describing the poster

All submitted abstracts will be reviewed and decisions regarding acceptance will be made as abstracts are received. You will be notified within one week of receipt about acceptance. Further details and registration materials will be provided at that time. You do not have to be present in order to have a poster displayed. Only those abstracts approved by LabRoots may display posters at this event.

If accepted, you will also have the opportunity to record a 3-5 minute summary video for each poster. LabRoots will work with each individual to create these videos. Video links and email contact information will be included on each poster displayed.

Questions? Email Posters@LabRoots.com

LabRoots Policy

Agenda
  • JUN 20, 2018 06:00 AM PDT
    Speaker: Christoph Endrullat, MS
  • JUN 20, 2018 07:30 AM PDT
    Speaker: Niall Lennon, PhD
  • JUN 20, 2018 09:00 AM PDT
    Speaker: Rupert Yip, PhD
    Sponsored By: QIAGEN
  • JUN 20, 2018 09:00 AM PDT
    Speaker: Nikolaus Schultz, PhD
  • JUN 20, 2018 10:30 AM PDT
    Speaker: Jahan Marcu, PhD, PFC
  • JUN 20, 2018 10:30 AM PDT
    Laurence Meyer, MD, PhD
    Chief Officer of Specialty Care Services, Veteran Healt...
    Ronald Przygodzki, MD
    Director of Genomic Medicine and Implementation, Depart...
  • JUN 20, 2018 12:00 PM PDT
    Speaker: Prasun Mishra, MsC, PhD
  • JUN 20, 2018 01:30 PM PDT
    Speaker: Neil Belson
  • JUN 21, 2018 06:00 AM PDT
    Speaker: Stephen Kingsmore, MD
  • JUN 21, 2018 07:30 AM PDT
    Speaker: Andres Hurtado-Lorenzo, PhD
  • JUN 21, 2018 09:00 AM PDT
    Speaker: Marty Tenenbaum, PhD
  • JUN 21, 2018 10:30 AM PDT
    Speaker: Paul Hofman, MD, PhD
    Sponsored By: QIAGEN
  • JUN 21, 2018 12:00 PM PDT
    Speaker: David Smith, PhD
  • JUN 21, 2018 01:30 PM PDT
    Speaker: Daniel Mueller, PhD
  • What's Next in Precision Medicine
  • JUN 20, 2018 06:00 AM PDT
    Speaker: Christoph Endrullat, MS
  • JUN 20, 2018 07:30 AM PDT
    Speaker: Niall Lennon, PhD
  • JUN 20, 2018 09:00 AM PDT
    Speaker: Rupert Yip, PhD
    Sponsored By: QIAGEN
  • JUN 20, 2018 10:30 AM PDT
    Laurence Meyer, MD, PhD
    Chief Officer of Specialty Care Services, Veteran Healt...
    Ronald Przygodzki, MD
    Director of Genomic Medicine and Implementation, Depart...
  • JUN 20, 2018 12:00 PM PDT
    Speaker: Prasun Mishra, MsC, PhD
  • JUN 20, 2018 01:30 PM PDT
    Speaker: Neil Belson
  • New Developments in Cancer Diagnostics and Therapeutics
  • JUN 20, 2018 09:00 AM PDT
    Speaker: Nikolaus Schultz, PhD
  • JUN 21, 2018 09:00 AM PDT
    Speaker: Marty Tenenbaum, PhD
  • JUN 21, 2018 12:00 PM PDT
    Speaker: David Smith, PhD
  • Pharmacogenomics
  • JUN 20, 2018 10:30 AM PDT
    Speaker: Jahan Marcu, PhD, PFC
  • JUN 21, 2018 01:30 PM PDT
    Speaker: Daniel Mueller, PhD
  • Disease-Specific Research
  • JUN 21, 2018 06:00 AM PDT
    Speaker: Stephen Kingsmore, MD
  • JUN 21, 2018 07:30 AM PDT
    Speaker: Andres Hurtado-Lorenzo, PhD
  • JUN 21, 2018 10:30 AM PDT
    Speaker: Paul Hofman, MD, PhD
    Sponsored By: QIAGEN
Speakers

  • Niall Lennon, PhD
    Senior Director of Translational Genomics and Product Development, Institute Scientist, Broad Institute of MIT and Harvard
    Biography
      Niall J. Lennon, PhD, is Senior Director of Translational Genomics and Product Development with the Genomics Platform at the Broad Institute of MIT & Harvard. Niall has been working on NGS applications and technology development at the Broad for over 11 years. Most recently, Dr. Lennon oversaw the creation, certification and launch of a CLIA certified & CAP accredited laboratory within the Broad. He led the efforts to validate and implement a clinical Whole Exome sequencing test for both germline and somatic samples. Niall is currently an Adjunct Assistant Professor of Biomedical Engineering at Tufts University. Niall has received a Black Belt in Six Sigma for his work on process design and optimization. He also holds an executive certificate in Management and Leadership from the MIT Sloan School of Management. Niall earned a PhD in Pharmacology, and a BSc from University College Dublin, Ireland.
    • Neil Belson
      Counsel, Potomac Law Group
      Biography
        Neil A. Belson is Of Counsel at Potomac Law Group, in Washington, D.C., where he handles transactional and regulatory compliance matters. He focuses on Precision Medicine, Life Sciences and Information Technology. Mr. Belson has also been an entrepreneur, and has founded, run and sold an industrial biotechnology business. Mr. Belson received his J.D. cum laude from Harvard Law School, and received B.S. and M.S. degrees from the University of Maryland. Mr. Belson also served as a Peace Corps Volunteer in the Dominican Republic.
      • Christoph Endrullat, MS
        Independent Freelancer
        Biography
          Christoph Endrullat is an independent freelancer in the life science and healthcare sector. Beforehand he held positions as a key account manager for oncology at Merck/EMD Group and as a scientific staff member in the Molecular Biotechnology and Functional Genomics division of the Technical University of Applied Sciences Wildau. His research interest and current expertise relies on next-generation sequencing (NGS) in association with precision medicine with a special focus on standardization and quality management. Especially, his efforts in the development and establishment of standards for NGS with the promising application in clinical oncology/precision medicine led to several delegations in authorities and projects. The ISO/TC 276 'Biotechnology', an expert group of the European Commission (JRC) as well as the COST Action CHARME represent his recent affiliations. His academic career comprised a Master of Science in Biotechnology from the University of Glasgow (UK) and a Bachelor of Science in Biosystems Technology/Bioinformatics from the Technical University of Applied Sciences Wildau (Germany). Further, he has published different scientific papers and gave presentations on diverse conferences and workshops.
        • Paul Hofman, MD, PhD
          Head of the Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, Head of the Human Biobank Unit, Pasteur Hospital
          Biography
            Paul Hofman obtained his MD degree in 1989 at the University Côte d'Azur (Nice, France) and his PhD in 1994 at the University of Montpellier I (Montpellier, France). Having completed research fellowships in the Department of Pathology at the Brigham and Women's Hospital (Harvard Medical School, Boston, USA) and at the Max Planck Institut (Tubingen, Germany), he became full Professor of Pathology and Head of a research team at the Inserm 1081/UMR CNRS 7284 (IRCAN; www.ircan.org), located at the Comprehensive Cancer Center Antoine Lacassagne (Nice) in 1995. His group's research focus is lung cancer pathophysiology and the discovery of predictive and prognostic biomarkers. Paul is also head of the Hospital-related Biobank (BB-0033-00025) and of the Laboratory of Clinical and Experimental Pathology at Nice Hospital as well as being Director of the OncoAge Consortium in France (www.oncoage.org). He has published more than 450 peer review publications.
          • Andres Hurtado-Lorenzo, PhD
            Senior Director of Translational Research, Crohn's & Colitis Foundation
            Biography
              Dr. Andrés Hurtado-Lorenzo is the Senior Director of Translational Research at the Crohn's and Colitis Foundation. He is responsible for planning and oversight the Foundation's translational research portfolio that consist of a number research initiatives in the fields of: Precision Medicine, Genetics, Microbiome, Environmental Triggers, and Entrepreneurial Investing, a venture philanthropy initiative focused on accelerating product development in IBD. These initiatives aim to identify opportunities to translate observations in the laboratory and clinic into interventions that reach and benefit patients; from therapeutics and diagnostics to medical devices and procedures. Dr. Hurtado-Lorenzo is a translational scientist leader with previous proven success directing multidisciplinary teams focused on drug discovery and development for neurological diseases and rare diseases in the biotech and pharmaceutical industry (Wyeth, Pfizer, Proteostasis Therapeutics) from discovery to early clinical development. These efforts have resulted in the identification of candidate drugs currently evaluated in clinical trials. He obtained his Ph.D. in Molecular Medicine from the University of Manchester in the UK, where he pioneered work in the field of viral gene therapy for neurodegenerative diseases. He completed his postdoctoral work at Harvard Medical School, Massachusetts General Hospital and Columbia University, where he conducted groundbreaking research focused on molecular mechanisms of autophagy and other protein degradation pathways and their role in health and disease. His research has been published in books high impact factor publications like Nature Cell Biology and Nature Communications.
            • Stephen Kingsmore, MD
              President and CEO, Rady Children's Institute for Genomic Medicine
            • Jahan Marcu, PhD, PFC
              Director and Chief Scientific Officer, Americans For Safe Access
              Biography
                Jahan Marcu, Ph.D., is currently the Chief Science Officer at Americans for Safe Access (a medical cannabis patient advocacy non-profit) and Director of the Patient Focused Certification program, which is a health and safety oversight program that assesses regulatory compliance at cannabis operations. He is co-founder of the International Research Center on Cannabis and Mental Health and is on the scientific advisory board of the International Cannabis and Cannabinoid Institute (Czech Republic). He is also co-founder and past-chairman of the CANN subdivision of the Chemical Health and Safety Division (DCHAS) of the American Chemical Society. His is also on the Board of Directors of the International Association for Cannabinoids as Medicine (Germany). He has a background in analytical chemistry and molecular pharmacology, he received his Ph.D. for contributions in characterizing the structure and function of the cannabinoid receptors. He is an author of the American Herbal Pharmacopeia's Cannabis Monograph and serves on multiple expert government, trade association committees, scientific organizations and is a court-qualified synthetic cannabinoid and cannabis expert. He has helped create the first standards for the medical cannabis industry with the American Herbal Products Association, as well as related educational training for clinicians and workers in the industry. He has been invited to speak at many international conferences, universities, hospitals, including the University of Leiden, Temple University School of Medicine, Princeton Hospital, and Yale University. Dr. Marcu is a recipient of the Billy Martin research award from the International Cannabinoid Research Society.
              • Laurence Meyer, MD, PhD
                Chief Officer of Specialty Care Services, Veteran Health Administration
                Biography
                  Dr. Meyer is the Chief Officer of Specialty Care Services and National Director of Genomic Medicine for the Veterans Health Administration. He is a professor of Dermatology and Internal Medicine at the University of Utah Health Sciences Center. He received his Ph.D. in Molecular Genetics from the University of California at Davis. He studied Medicine at the University of Miami, Florida, and has active board certifications in Internal Medicine, Dermatology and Clinical Genetics. Dr. Meyer has responsibility for the Pain service in the VA and he also has overall oversight of VA policy on opioids. He leads the clinical Genomic Medicine Service which is a centralized clinical telehealth service which delivers genetic service to Veterans in over 80 VA hospitals nationwide.
                • Prasun Mishra, MsC, PhD
                  Founder and CEO of Agility Pharmaceuticals, CEO, American Association for Precision Medicine
                  Biography
                    Dr. Mishra (Ex-Genentech, Ex-NCI, Ex-NIH, Ex-Rutgers) is the Founder and CEO of Agility Pharmaceuticals. He is also founding president and CEO of American Association for Precision Medicine (AAPM). He is best known for discovering the role for noncoding RNA in drug resistance and pharmacogenomics. Moreover, his passion for drug development and precision medicine has led to identification of new drug targets, biomarkers, companion diagnostics, and mechanisms of action/resistance of both new and established drugs, which has facilitated development of rational drug combinations in the clinic. While at Genentech, besides translational research, he participated in discovery project teams at various stages. He was instrumental in establishing robotic automation (robotization) driven mammalian cell based phenotypic screening capabilities and hit to lead identification efforts within Genentech. His research work has been recognized globally by numerous awards and honors. In addition to his professional commitments, Dr. Mishra also gives back to his local biotech community by serving as an advisor to several companies in the San Francisco Bay Area to advance their R&D and funding strategy. The companies that he has advised have raised multimillion dollars. Notably, he serves as a mentor and advisor to startup accelerators such as IndieBio, Project Zygote and California Life Sciences Association, to help grow California's life sciences innovation ecosystem. Moreover, discoveries lead by Dr. Mishra and his teams have contributed to the development of new and viable strategies of prevention, diagnosis and treatment of patients in the clinic.
                  • Daniel Mueller, PhD
                    Head of the Pharmacogenetics Research Clinic at the Campbell Family Mental Health Research Institute at CAMH, and Associate Professor in the Department of Psychiatry at the University of Toro
                    Biography
                      Dr. Mueller earned his MD at the University of Bonn (Germany) and completed his residency training in Psychiatry at the Charité University Clinic in Berlin. In 2008, he has been appointed at the University of Toronto (Department of Psychiatry), and as Clinician Scientist at CAMH. At the same time, he became Head of the Pharmacogenetics Research Clinic at CAMH which is one of the first of its kind worldwide to develop clinical implementation strategies (e.g., Müller DJ et al., 2013; PMID:24151801). Dr. Mueller's overall research goals are to investigate genetic causes of response and side effects to psychiatric medications. This line of research aims to significantly improve treatment of psychiatric conditions and to lessen the burden of medication side effects and to avoid negative drug-drug interactions. In addition, he is actively involved in developing pharmacogenetic guidelines for physicians and patients and is affiliated with the Clinical Pharmacogenetics Implementation Consortium (Caudle et al., 2014; PMID: 24479687). For more information, visit www.pharmacogenetics.ca For a complete publication record, see: https://scholar.google.de/citations?user=lnbto4AAAAAJ&hl=de
                    • Ronald Przygodzki, MD
                      Director of Genomic Medicine and Implementation, Department of Veterans Affairs
                      Biography
                        Ronald M. Przygodzki, M.D. holds a degree in medicine from the Medical University of Warsaw, Poland. He is board certified in anatomic and clinical pathology (American Board of Pathology), with subspecialization in molecular genetic pathology (American Board of Pathology and American Board of Medical Genetics). He has over 25 years of research and clinical experience with over 15 years of administrative experience. He is Director of Genomic in Implementation, and Associate Director of the Genomic Medicine Program. His previous leadership roles (private and public sectors) include being Director, Biomedical Laboratories R&D at the US Department of Veterans Affairs, as Chief of Pathology at the Children's National Medical Center and as Associate Director of the Molecular Diagnostics Laboratory at the Armed Forces Institute of Pathology, all in Washington DC. He conceptualized, drafted and guided implementation of the Million Veterans Program, one of the largest mega-biobank worldwide. Dr. Przygodzki's research expertise and interests are in anatomic and clinical pathology and molecular genomics, spanning from the theoretical to practical clinically translatable arenas. He has developed unique molecular-based techniques-in particular, ones invented around the use of small archival tissue specimens typically found in pathology. He has authored numerous publications, book chapters, and books. Some of his molecular pathology research efforts led to the reclassification of two pulmonary malignancies by the World Health Organization, and have allowed him to receive national and international recognition. His current aims are targeting pharmacogenomic combinatorial analyses to help guide opioid and major depression therapies.
                      • Nikolaus Schultz, PhD
                        Head of Knowledge Systems, Marie-Josée & Henry R. Kravis Center for Molecular Oncology
                        Biography
                          Nikolaus Schultz leads the development of the cBioPortal for Cancer Genomics, a popular resource for the visualization and analysis of large-scale cancer genomics data sets. His research focuses on identifying the genomic alterations that underlie different types of cancer. He is involved in several projects of The Cancer Genome Atlas (TCGA) and is an investigator in the Stand Up To Cancer (SU2C) Prostate Cancer Dream Team. Dr. Schultz is an Associate Attending Computational Oncologist in the Department of Epidemiology and Biostatistics and an affiliate member of the Human Oncology and Pathogenesis Program. He is the Head of Knowledge Systems in the Marie-Josée and Henry R. Kravis Center for Molecular Oncology.
                        • David Smith, PhD
                          Professor and Consultant at Mayo Clinic
                          Biography
                            David I Smith received his Ph.D. in Biochemistry from the University of Wisconsin in Madison in 1978 studying antibiotic resistance in bacteria. After doing post-doctoral work first at the Albert Einstein College of Medicine and then at the University of California, Irvine, he got his first faculty position at Wayne State University in 1985. In 1996 he joined the Mayo Clinic as a full Professor in the Department of Laboratory Medicine and Pathology. His laboratory studies the common fragile sites which are regions of profound genomic instability that are found in all individuals. His laboratory also studies the various ways that human papillomavirus is involved in the generation of different cancers. Dr. Smith is also the Chairman of the Technology Assessment Group for the Mayo Clinic Center for Individualized Medicine. The role of this group is to evaluate new technologies that could have a profound impact on basic research and its' clinical translation. The most exciting technology that has the greatest potential to change both research and clinical practice is next generation sequencing and Dr. Smith and his group have been using this technology to answer scientific questions. The advances in next generation sequencing over the past 10 years have been nothing short of incredible and it is now possible to generate terrabases of DNA sequence in a single run of a next generation sequencer. This technology can be utilized in a number of ways from characterizing just a few genes all the way to whole genome sequencing.
                          • Marty Tenenbaum, PhD
                            Founder and Chairman at Cancer Commons
                            Biography
                              Dr. Jay M. ("Marty") Tenenbaum, a world-renowned Internet commerce pioneer and visionary, founded CommerceNet (1994) to accelerate business use of the Internet. While at CommerceNet, he co-founded Veo Systems (1997), the company that pioneered the use of XML for automating business-to-business transactions. When Commerce One acquired Veo Systems in January 1999, Dr. Tenenbaum became chief scientist and was instrumental in shaping the company's business and technology strategies for the Global Trading Web. Post Commerce One, Dr. Tenenbaum was an officer and director of Webify Solutions (sold to IBM in 2006) and Medstory (sold to Microsoft in 2007). Currently, his focus is on transforming healthcare and accelerating therapy development through collaborative e-science. Towards that end, he founded CollabRx, which builds "virtual biotechs" to help slash the time, cost, and risk of developing new therapies." Prior to CommerceNet, he was founder and CEO of Enterprise Integration Technologies, the first company to conduct a commercial Internet transaction (1992), secure Web transaction (1993), and Internet auction (1993). Earlier in his career, Dr. Tenenbaum was also a prominent AI researcher, and led AI research groups at SRI International and Schlumberger Ltd. Dr. Tenenbaum is a fellow and former board member of the American Association for Artificial Intelligence, and a former consulting professor of Computer Science at Stanford. He currently serves as a director of Efficient Finance, Patients Like Me, and the Public Library of Science, and is a consulting professor of Information Technology at Carnegie Mellon's new West coast campus. Dr. Tenenbaum holds B.S. and M.S. degrees in Electrical Engineering from MIT, and a Ph.D. from Stanford.
                            • Rupert Yip, PhD
                              Associate Director, Genetic Disease Informatics at QIAGEN
                            Sponsored By

                            For information on becoming a sponsor or exhibitor, please click here.


                            Committee

                            To download the Program Committee brochure here.


                            • Sarah Elsea, PhD

                              Dr. Sarah H. Elsea is an Associate Professor of Molecular and Human Genetics at Baylor College of Medicine and is Senior Division Director of Biochemical Genetics at Baylor Genetics. Dr. Elsea earned a B.S. in chemistry from Missouri State University and Ph.D. in biochemistry ...

                              See more See less
                            • Iya Khalil, PhD

                              Iya Khalil, co-founder and executive vice president of GNS, has promoted use of the Cambridge, MA-based company's technology in the biopharma industry. One of the inventors of the company's computational platform, her work has helped major players such as Biogen Idec and Johnson ...

                              See more See less
                            • Tatjana Matejic, PhD, D(ABMLI)

                            • Giacinto Scoles, PhD

                              Giacinto Scoles (b. 1935, married to Lim Giok Lan since 1964) is Donner professor of Science, Emeritus at Princeton University, distinguished adjoint professor in the Departments of Physics and Biology at Temple University, and distinguished scientist at Synchrotron Elettra in ...

                              See more See less
                            • Ruth Luna, PhD, MB (ASCP) CM

                              Dr. Ruth Ann Luna serves as Assistant Professor in the Department of Pathology & Immunology of Baylor College of Medicine and as Director of Medical Metagenomics within the Texas Children's Microbiome Center at Texas Children's Hospital. Dr. Luna directs the next-generation ...

                              See more See less
                            • David Smith, PhD

                              David I Smith received his B.S. in Mathematics and Molecular Biology from the University of Wisconsin in Madison. He then received his Ph.D. for the Department of Biochemistry also at the University of Wisconsin in Madison. After several postdoctoral positions he got his first ...

                              See more See less
                            • Daniel Mueller, PhD

                              Dr. Mueller earned his MD at the University of Bonn (Germany) and completed his residency training in Psychiatry at the Charité University Clinic in Berlin. In 2008, he has been appointed at the University of Toronto (Department of Psychiatry), and as Clinician Scientist at ...

                              See more See less
                            • Marty Tenenbaum, PhD

                              Dr. Jay M. ("Marty") Tenenbaum, a world-renowned Internet commerce pioneer and visionary, founded CommerceNet (1994) to accelerate business use of the Internet. While at CommerceNet, he co-founded Veo Systems (1997), the company that pioneered the use of XML for automating ...

                              See more See less
                            Help

                            General LabRoots Questions

                            For bugs, spam, technical support or questions please call +1-714-463-4673 or email support@labroots.com  
                            Contact us

                            Virtual Events and Webinars

                            Supported Configurations

                            • Operating System Internet Explorer Firefox Chrome Safari
                              Vista IE8+ FF10+ Chrome15+
                              Windows 7 IE8+ FF10+ Chrome15+
                              Windows 8 IE10 FF10+ Chrome15+
                              Mac OS X   FF10+ Chrome15+ Safari5.1+
                            • Cookie settings: session cookies enabled
                            • Browser configuration must have JavaScript enabled
                            • Adobe Flash player 10.2 or later

                            To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                            Internet Connection

                            • A minimum of 100Kbps is recommended for audio-only events
                            • A minimum of 300Kbps is recommended for speaker on-video events

                            Computer Equipment

                            • Screen Resolution: Minimum 1024x768
                            • Video Card: 65,000 colors minimum
                            • Sound card and speakers (or headphones) for hearing webcast in full format
                            • Audio Card: 16-bit minimum
                            • RAM: 512MB of free RAM

                            Firewall Protocol

                            • HTTP on port 80 or HTTPS on port 443
                            • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                            • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                            Work-At-Home Attendees

                            • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                            For A Seamless Experience

                            When using a mobile device, FREE Mobile Apps are available:

                            - For viewing Webinars:

                            - For viewing Virtual Events

                            Attendee Guide

                            • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                            Virtual Event and Webinar Support:

                            Continuing Education (CME/CE) Support

                            Loading Comments...
                            Show Resources